New allergy shot could ease birch pollen misery
NCT ID NCT07155499
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 23 times
Summary
This study tests a new medicine called GNR-127 for people with seasonal allergies to birch pollen. The goal is to see if it safely reduces symptoms like sneezing, runny nose, and itchy eyes. About 150 adults aged 18-55 will take part, first to find the right dose, then to compare it to a placebo over five months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHINITIS, ALLERGIC, SEASONAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Research Center - Institute of Immunology Federal Medical-Biological Agency
Moscow, 115522, Russia
Conditions
Explore the condition pages connected to this study.